Return

NAME

Caroline B. Appleyard

TITLE

Associate Professor

EDUCATION AND TRAINING

Institutions and Locations

Degree Years(s) Field of Study
University of Edinburgh,
United Kingdom

University of Southampton,
United Kingdom

University of Calgary, Canada

University of South Dakota, USA
B Sc


PhD


Post-Doc.

Post-Doc.
1989


1993


1993-1996

1996-1998
Pharmacology


Pharmacology


GI Phys/Pharm.

GI Phys/Pharm.

POSITIONS AND HONORS
Positions and Employment
1990-1992


1993-1996


1996-1998


1998-2001


2001-presen
t
Research Instructor, Deptartment of Clinical Pharmacology, University of Southampton, UK

Post-Doctoral Fellow, Gastrointestinal Research Group,
University of Calgary, AB, Canada

Post-Doctoral Fellow, Department of Physiology & Pharmacology, University of South Dakota, SD

Assistant Professor, Department of Physiology,
Ponce School of Medicine, Ponce, PR

Associate Professor, Department of Physiology,
Ponce School of Medicine, Ponce, PR
Other Experience and Personnel Experience

1997-1998


1997-present

1997-present

1998-present

1999-present


1999-present



1999-present

2000-present

2003-present

2004, 2005

Graduate Research Seminar Committee/Supervision of Undergraduate & High School Students

Member, American Physiology Society

Member, American Gastroenterological Association

Member, Gastroenterology Research Group

Chair, Institutional Animal Care and Use Committee at Ponce School of Medicine, Ponce, PR

Ad-hoc Peer Reviewed for Laboratory Investigation (99), Journal of Pharmacology and Experimental Therapeutics (99, 00, 01, 02), American Journal of Physiology (02, 03, 04)

Member, American Association for the Advancement of Science

Member, American Motility Society

Ad-hoc Member, NIGMS/MBRS Review Panel

Member, Abstract Selection Comitte, American Gastroenterological Association
Honors
1989-1990

1993-1994

1993

1995

2000

2002, 03, 04
University of Southampton Graduate Studentship

Wellcome Trust Travel Grant

Fellowship from the Canadian Association of Gastroenterology

Young Investigator Award (FASEB Summer Research Conference)

American Motility Society Travel Award

FASEB/MAC Travel Award
Selected Peer-Reviewed Publications


Bessos H, Appleyard CB, Micklem LR, and Pepper DS. (1991) Monoclonal antibody leakage from gels: Effect of support, activation, and eluent composition. Preparative Chromatography. 1(3):207-220.
Impact Factor: NA

Appleyard CB and Hillier K. (1992) Catabolism of platelet activating factor (PAF) by human colonic mucosa: calcium dependence of the catabolising enzymes. Biochemical Pharmacology. 43(12):2503-2509. Impact Factor: (1992): 2.219.

Appleyard CB and Hillier K. (1995) Biosynthesis of platelet activating factor (PAF) in normal and inflamed human colon mucosa: Evidence for the involvement of the de novo pathway of PAF synthesis in inflammatory bowel disease. Clinical Science. 88(6):713-717. Impact Factor: (1995): 2.070.

Wallace JL, Le T, Carter L, Appleyard CB, and Beck PL. (1995) Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzenesulfonic acid. Journal of Pharmacological and Toxicological Methods. 33(4):237- 239. Impact Factor: (1995): 0.758.

Appleyard CB and Wallace JL. (1995) Reactivation of hapten-induced colitis and its prevention by anti- inflammatory drugs. American Journal of Physiology-Gastrointestinal and Liver Physiology. 269(1 pt 1):G119-125. Impact Factor: NA.

Appleyard CB, McCafferty D-M, Tigley AW, Swain MG, and Wallace JL. (1996) Tumor necrosis factor mediation of NSAID-induced gastric damage: Role ofleukocyte adherence. American Journal of Physiology-Gastrointestinal and Liver Physiology. 270(1):G42-48. Impact Factor: NA.

Davies NM, Roseth AG, Appleyard CB, McKnight W, Del Soldato P, Calignano A, Cirino G, and Wallace JL. (1997) NO-Naproxen vs. Naproxen: Ulcerogenic, analgesic, and anti-inflammatory effects. Alimentary Pharmacology and Therapeutics. 11(1):69-79. Impact Factor: (1997): 3.004.

Ferraz JGP, Tigley AW, Appleyard CB, and Wallace JL. (1997) TNF-a contributes to the pathogenesis of ethanol-induced gastric damage in cirrhotic rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 272(4 Pt 1):G809-814. Impact Factor: NA.

Swain MG, Appleyard CB, Wallace JL, and Maric M. (1997) TNF-a facilitates inflammation-induced glucocorticoid secretion in rats with biliary obstruction. Journal of Hepatology. 26(2):361-368. Impact Factor (1997): 5.849.

Swain MG, Appleyard CB, Wallace J, Wong H, and Le, T. (1999) Endogenous glucocorticoids released during acute toxic liver injury enhance hepatic IL-10 synthesis and release. American Journal of Physiology-Gastrointestinal and Liver Physiology. 276(1 pt 1):G199-205. Impact Factor (1999): 3.228.

Hathaway CA, Appleyard CB, Percy WH, and Williams JL. (1999) Experimental colitis increases blood-brain barrier permeability in rabbits. American Journal of Physiology-Gastrointestinal and Liver Physiology. 276(5 pt 1): G1174-1180. Impact Factor (1999): 3.228.

Appleyard CB, Williams JL, Hathaway CA, and Percy WH. (1999) Temporal patterns of colonic blood flow and tissue damage in an animal model of colitis. Digestive Diseases and Sciences 44:413-438. Impact Factor (2003): 2.183.

Asfaha S, MacNaughton WK, Appleyard CB, Chadee K, and Wallace JL. (2001) Persistent epithelial dysfunction and bacterial translocation after resolution of colitis in the rat. American Journal of Physiology-Gastrointestinal and Liver Physiology-Gastrointestinal and Liver Physiology. 281(3):G635-644. Impact Factor (2001): 3.660.

Appleyard CB, Alvarez A, and Percy WH. (2002) Temporal changes in colonic vascular architecture and inflammatory mediator levels in animal models of colitis. Digestive Diseases and Sciences. 47(9):2007-2014. Impact Factor (2002): 1.438.

Hernández GA and Appleyard CB. (2003) Bacterial load in animal models of acute and chronic "reactivated" colitis. Digestion. 67(3):161-169. Impact Factor (2003): 1.399.

Appleyard CB, Hernández GA, and Ríos-Bedoya CF. (2004) Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflammatory Bowel Diseases. 10(2):106-111. Impact Factor (2003): 3.023.

Hernández GA, Valentín MR, and Appleyard CB. Effect of bacterial peptides on intestinal inflammation in animal models of acute and chronic “relapsed” colitis. Digestive Diseases. In Press. Impact Factor (2003): 1.387.

Rojas-Cartagena C, Flores I, and Appleyard CB. Role of tumor necrosis factor receptors in an animal model of acute colitis. Cytokine. In Press. Impact Factor (2003): 2.183.

Recent Abstracts
Rojas C, Flores I, Santiago C, Santiago I, and Appleyard CB. (2003) Pathophysiological role of TNF-RI in an animal model of Inflammatory Bowel Disease. FASEB Journal. 17, no. 5, A964.

Hernández GA and Appleyard CB. (2003) The effect of formyl-methionyl-leucyl-phenylalanine (FMLP) on intestinal inflammation in models of acute and relapsed phase of colitis. Gastroenterology. 126, no. 4, Suppl. LA480.

Rojas C, Appleyard CB, Santiago OI, Santiago C, Resto K, and Flores I. (2003) TRAF 1 overexpression in an animal model of intestinal endometriosis. Biology of Reproduction. 68 (supplement I): A400.

Appleyard CB, Morales M, Cuevas M, and Santiago C. (2004) Phosphodiesterase inhibition can ameliorate chronic intestinal inflammation. FASEB Journal. 18, no. 5, A1265.
RESEARCH SUPPORT
Ongoing Research Support
NIH-NIGMS-MBRS S06 GM 08239 Appleyard (PI; Torres PD) 06/01/01 - 05/31/05
Involvement of TNF in Intestinal Inflammation in a Reactivated Model of Colitis.
Major goals: To measure the levels of TNF alpha following colitis induction and correlate with intestinal inflammation and secretion. Investigate the effects of inhibition of TNF alpha on the above parameters.
Role: PI

NIH-NIGMS-MBRS S06 GM 08239 Flores (PI; Torres PD) 06/01/02-05/31/05
Differentiation of TNF pathways in Intestinal Endometriosis and Crohn's Disease
Major goals: The long term goal of this project is to develop a non-invasive diagnostic test that will differentiate between intestinal endometriosis and inflammatory bowel disease. The differential activation of TNF receptors and the associated signaling molecules in acute inflammation will be determined.
Role: Co-Investigator

NIH-NCRR/RCMI 2G12 RR03050 Appleyard (PI; Yamamura PD) 09/30/03 - 06/30/08
Role of Bacterial Peptides in Chronic Intestinal Inflammation
Major goals: To determine whether the bacterial peptide fMLP can exacerbate intestinal inflammation in the acute and chronic phase of colitis by altering the secretory and motility responses of the intestine. Levels of inflammatory and proinflammatory cytokines will be measured.
Role: PI
Completed Research Support
ES-01 -004 Yano (PI) 09/01/01-08/31/03
Nutritional Regulation of Catalase and Colorectal Cancer
The overall goal of this project is to understand the mechanisms of butyrate-dependent catalase regulation with a view to developing new strategies to control colon cancer.
Role: Co-Investigator

Return